Irina Sidina

Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids

François Chasset, Cécile Pagès, Lucie Biard et al. · European Journal of Dermatology · 2015 · 42 citations

Medicine, Oncology, Pharmacotherapy +17

Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response

Joana Félix, Jérôme Lambert, Marie Roelens et al. · OncoImmunology · 2016 · 32 citations · Full text

Life Sciences, Immunology, Oncology +17

BRAF V600 mutation levels predict response to vemurafenib in metastatic melanoma

Célèste Lebbé, Alexandre How‐Kit, Maxime Battistella et al. · Melanoma Research · 2014 · 26 citations

Medicine, Molecular Genetics, Oncology +14

Vemurafenib in the French temporary authorization for use metastatic melanoma cohort

Fériel Fennira, Cécile Pagès, Pierre Schneider et al. · Melanoma Research · 2013 · 22 citations

Medicine, Oncology, Pharmacology +15